LSNGX
Price
$25.43
Change
-$0.01 (-0.04%)
Updated
Oct 17 closing price
Net Assets
136.7M
RNPCX
Price
$71.36
Change
+$0.14 (+0.20%)
Updated
Oct 17 closing price
Net Assets
162.58B
Interact to see
Advertisement

LSNGX vs RNPCX

Header iconLSNGX vs RNPCX Comparison
Open Charts LSNGX vs RNPCXBanner chart's image
Loomis Sayles Global Growth N
Price$25.43
Change-$0.01 (-0.04%)
VolumeN/A
Net Assets136.7M
American Funds New Perspective R3
Price$71.36
Change+$0.14 (+0.20%)
VolumeN/A
Net Assets162.58B
LSNGX vs RNPCX Comparison Chart in %
View a ticker or compare two or three
VS
LSNGX vs. RNPCX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSNGX is a Buy and RNPCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 163B vs. LSNGX (137M). RNPCX pays higher dividends than LSNGX: RNPCX (0.21) vs LSNGX (0.00). LSNGX was incepted earlier than RNPCX: LSNGX (9 years) vs RNPCX (23 years). LSNGX (1.06) and RNPCX (1.06) have similar cost to investors . RNPCX is a more actively managed with annual turnover of: 24.00 vs. LSNGX (6.00). RNPCX has a lower initial minimum investment than LSNGX: RNPCX (250) vs LSNGX (1000000). LSNGX annual gain was more profitable for investors over the last year : 25.63 vs. RNPCX (12.07). LSNGX return over 5 years is better than : 40.17 vs. RNPCX (32.67).
LSNGXRNPCXLSNGX / RNPCX
Total Expense Ratio0.901.0685%
Annual Report Gross Expense Ratio1.061.06100%
Fund Existence9 years23 years-
Gain YTD21.20118.562114%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets137M163B0%
Annual Yield % from dividends0.000.21-
Returns for 1 year25.6312.07212%
Returns for 3 years98.5959.82165%
Returns for 5 years40.1732.67123%
Returns for 10 yearsN/A94.25-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLDX26.830.28
+1.05%
Celldex Therapeutics
IMPPP25.20N/A
N/A
Imperial Petroleum
MOV17.87-0.03
-0.17%
Movado Group
VTSI5.65-0.07
-1.22%
VirTra
OVV35.97-0.47
-1.29%
Ovintiv